Maximus, Inc. (NYSE:MMS – Get Free Report) shares hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $56.92 and last traded at $59.4150, with a volume of 45899 shares traded. The stock had previously closed at $59.90.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on MMS shares. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings lowered shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday. Finally, Wall Street Zen downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Maximus currently has an average rating of “Hold”.
Get Our Latest Research Report on Maximus
Maximus Price Performance
Maximus (NYSE:MMS – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 EPS for the quarter, topping analysts’ consensus estimates of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. During the same period in the previous year, the firm earned $2.01 earnings per share. The firm’s quarterly revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Equities research analysts forecast that Maximus, Inc. will post 8.4 EPS for the current fiscal year.
Maximus Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Friday, May 15th will be paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Friday, May 15th. Maximus’s dividend payout ratio is currently 19.76%.
Insiders Place Their Bets
In related news, Director Jan Madsen sold 742 shares of Maximus stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total transaction of $53,609.50. Following the completion of the transaction, the director owned 20,795 shares of the company’s stock, valued at $1,502,438.75. This trade represents a 3.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.80% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the business. Richardson Financial Services Inc. boosted its position in shares of Maximus by 29.6% during the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after purchasing an additional 103 shares in the last quarter. Farther Finance Advisors LLC lifted its stake in Maximus by 69.0% in the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after buying an additional 116 shares during the period. Parkside Financial Bank & Trust boosted its holdings in shares of Maximus by 13.4% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,268 shares of the health services provider’s stock worth $109,000 after buying an additional 150 shares in the last quarter. Arizona State Retirement System boosted its holdings in shares of Maximus by 0.9% during the 3rd quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider’s stock worth $1,524,000 after buying an additional 156 shares in the last quarter. Finally, Blue Trust Inc. grew its position in shares of Maximus by 14.6% during the 1st quarter. Blue Trust Inc. now owns 1,321 shares of the health services provider’s stock worth $85,000 after buying an additional 168 shares during the period. 97.21% of the stock is owned by institutional investors.
Maximus Company Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Further Reading
- Five stocks we like better than Maximus
- Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
- Intuit’s Great SaaS Reset: Fired By AI
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
